Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SOLAZYME INC | 218,403 | reported | 09 Mar 2017 | tx 118+1,618,638−623,157 |
| Oruka Therapeutics, Inc. | 31,767 | reported | 16 Mar 2026 | tx 4+325,000−733 |
| CymaBay Therapeutics, Inc. | 0 | reported | 22 Mar 2024 | tx 49+1,367,499−981,054 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 733 | 41.30 USD | |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 32,500 | 0.00 USD | |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 22 Jan 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 162,500 | 0.00 USD | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 28,438 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 41,824 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 22,167 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 215,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 105,625 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 233,176 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 107,000 | — | deriv |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 41,824 | 7.89 USD | |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 41,824 | 0.00 USD | deriv |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 28,438 | 0.00 USD | |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 105,625 | 0.00 USD | deriv |
| 16 Jan 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 5,000 | 2.94 USD | |
| 16 Jan 2024 | SALE | CymaBay Therapeutics, Inc. | 5,000 | 23.58 USD | |
| 16 Jan 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 15 Dec 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5,000 | 2.94 USD | |
| 15 Dec 2023 | SALE | CymaBay Therapeutics, Inc. | 5,000 | 21.98 USD | |
| 15 Dec 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 15 Nov 2023 | SALE | CymaBay Therapeutics, Inc. | 5,000 | 17.38 USD | |
| 15 Nov 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5,000 | 2.94 USD | |
| 15 Nov 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 16 Oct 2023 | SALE | CymaBay Therapeutics, Inc. | 5,000 | 13.76 USD |